[AXDX] Accelerate Diagnostics, Inc.

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 22.3 Change: 0.2 (0.9%)
Ext. hours: Change: 0 (0%)

chart AXDX

Refresh chart

Strongest Trends Summary For AXDX

AXDX is in the long-term up 963% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Accelerate Diagnostics, Inc. focuses on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel system, a rapid diagnostic platform for rapid diagnosis in life-threatening infectious pathogens. It also develops and licenses OptiChem surface coatings for use in microarraying components. Accelerate Diagnostics, Inc. has a research collaboration with U.S. Centers for Disease Control and Prevention to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.

Fundamental Ratios
Shares Outstanding EPS-1.27 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 7.69% Sales Growth - Q/Q-82.28% P/E-21.97
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-54.67% ROE-58.87% ROI
Current Ratio17.04 Quick Ratio Long Term Debt/Equity Debt Ratio0.06
Gross Margin Operating Margin-28957.4% Net Profit Margin-28383.6% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities30 K Cash From Investing Activities760 K Cash From Operating Activities-6.96 M Gross Profit
Net Profit-8.9 M Operating Profit-9.56 M Total Assets63.34 M Total Current Assets59.66 M
Total Current Liabilities3.5 M Total Debt120 K Total Liabilities4.51 M Total Revenue10 K
Technical Data
High 52 week24.65 Low 52 week10.42 Last close19.3 Last change-1.48%
RSI46.79 Average true range0.97 Beta0.46 Volume123.45 K
Simple moving average 20 days-0.24% Simple moving average 50 days-1.24% Simple moving average 200 days4.16%
Performance Data
Performance Week-6.45% Performance Month5.18% Performance Quart-2.48% Performance Half34.03%
Performance Year-12.27% Performance Year-to-date67.83% Volatility daily2.5% Volatility weekly5.58%
Volatility monthly11.44% Volatility yearly39.61% Relative Volume281.89% Average Volume242.66 K
New High New Low

News

2019-11-08 16:30:14 | Seven Arizona companies ranked among fastest growing by Deloitte

2019-11-07 18:25:11 | Accelerate Diagnostics AXDX Reports Q3 Loss, Misses Revenue Estimates

2019-11-07 16:01:00 | Accelerate Diagnostics Reports Third Quarter 2019 Financial Results

2019-11-04 07:45:00 | Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors

2019-10-31 10:34:02 | Will Accelerate Diagnostics AXDX Report Negative Earnings Next Week? What You Should Know

2019-10-28 18:15:22 | Is Accelerate Diagnostics Inc AXDX Going To Burn These Hedge Funds ?

2019-10-17 08:00:00 | Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results

2019-10-03 08:00:00 | Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes

2019-09-19 08:00:18 | Just Two Stocks Turned Pennies Into Billions

2019-09-18 10:20:02 | Accelerate Diagnostics AXDX Jumps: Stock Rises 9.4%

2019-09-18 07:30:00 | Accelerate Diagnostics Highlights Clinical Endpoints Achieved Across Mayo Clinic/UCLA, University of Iowa, and UAMS Studies

2019-08-09 03:07:32 | Edited Transcript of AXDX earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-09 02:24:23 | Accelerate Diagnostics AXDX Q2 2019 Earnings Call Transcript

2019-08-08 18:05:10 | Accelerate Diagnostics AXDX Reports Q2 Loss, Misses Revenue Estimates

2019-08-08 16:06:00 | Accelerate Diagnostics Names Jack Phillips Chief Operating Officer

2019-08-08 16:01:00 | Accelerate Diagnostics Reports Second Quarter 2019 Financial Results

2019-08-05 12:18:45 | Some Accelerate Diagnostics NASDAQ:AXDX Shareholders Are Down 19%

2019-08-01 10:33:02 | Accelerate Diagnostics AXDX May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-07-15 14:15:15 | Arizona's most-profitable public companies raked in billions in 2018

2019-07-08 08:30:00 | Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results

2019-06-19 15:41:11 | Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. NASDAQ:AXDX?

2019-06-13 08:06:40 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-06-10 08:07:48 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-06-06 08:02:20 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-06-04 08:02:24 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-05-24 12:45:00 | Accelerate Diagnostics to Present at the William Blair Growth Stock Conference on June 6, 2019

2019-05-22 10:42:11 | You Can Get Buy Signals From Short Selling

2019-05-10 13:23:47 | Accelerate Diagnostics AXDX Q1 2019 Earnings Call Transcript

2019-05-09 21:55:05 | Edited Transcript of AXDX earnings conference call or presentation 9-May-19 8:30pm GMT

2019-05-09 18:05:10 | Accelerate Diagnostics AXDX Reports Q1 Loss, Misses Revenue Estimates

2019-05-09 17:01:27 | Accelerate Diagnostics: 1Q Earnings Snapshot

2019-05-09 16:01:00 | Accelerate Diagnostics Reports First Quarter 2019 Financial Results

2019-05-08 16:05:37 | Did Hedge Funds Drop The Ball On Accelerate Diagnostics Inc AXDX ?

2019-05-02 10:32:02 | Analysts Estimate Accelerate Diagnostics AXDX to Report a Decline in Earnings: What to Look Out for

2019-04-26 11:44:00 | Accelerate Diagnostics Schedules Call to Review First Quarter 2019 Results

2019-04-16 12:09:27 | Is Accelerate Diagnostics, Inc. NASDAQ:AXDX Trading At A 30% Discount?

2019-04-05 19:22:06 | Cramer studies Accelerate Diagnostics, Zix Corp., and Chemical Bank

2019-04-02 11:55:24 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-03-26 08:26:45 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-03-12 10:25:56 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-03-08 15:38:00 | Accelerate Diagnostics to Present at the Cowen and Company 39th Annual Health Care Conference on March 13, 2019

2019-03-05 08:06:55 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.

2019-03-01 07:48:07 | Accelerate Diagnostics Inc AXDX Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-02-26 08:25:28 | Should You Be Pleased About The CEO Pay At Accelerate Diagnostics, Inc.’s NASDAQ:AXDX

2019-02-21 07:28:16 | Edited Transcript of AXDX earnings conference call or presentation 19-Feb-19 9:30pm GMT

2019-02-19 20:05:03 | Accelerate Diagnostics Corp AXDX Q4 2018 Earnings Conference Call Transcript

2019-02-19 16:26:27 | Accelerate Diagnostics: 4Q Earnings Snapshot

2019-02-19 16:01:00 | Accelerate Diagnostics Reports 2018 Fourth Quarter and Full-Year Financial Results

2019-02-19 14:30:00 | Accelerate Diagnostics, Inc. to Host Earnings Call

2019-02-12 10:30:03 | Earnings Preview: Accelerate Diagnostics AXDX Q4 Earnings Expected to Decline